Patents by Inventor Hyung Ryong Moon
Hyung Ryong Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10045923Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: GrantFiled: August 28, 2015Date of Patent: August 14, 2018Inventors: Hae Young Chung, Min Hi Park, Young Mi Ha, Yu Kyeong Han, Ji Young Park, Yun Jung Park, Jin Ah Kim, Ji Yeon Lee, Yu Min Song, Hyung Ryong Moon
-
Patent number: 9896421Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: GrantFiled: December 18, 2015Date of Patent: February 20, 2018Assignee: Pusan National University Industry-University Cooperation FoundationInventors: Hae Young Chung, Hyung Ryong Moon, Min Hi Park, Young Mi Ha, Yun Jung Park, Ji Young Park, Jin Ah Kim, Ji Yeon Lee, Kyung Jin Lee
-
Publication number: 20160102065Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: ApplicationFiled: December 18, 2015Publication date: April 14, 2016Applicant: Pusan National University Industry-University Cooperation FoundationInventors: Hae Young CHUNG, Hyung Ryong MOON, Min Hi PARK, Young Mi HA, Yun Jung PARK, Ji Young PARK, Jin Ah KIM, Ji Yeon LEE, Kyung Jin LEE
-
Publication number: 20150366776Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: ApplicationFiled: August 28, 2015Publication date: December 24, 2015Inventors: Hae Young Chung, Min Hi Park, Young Mi Ha, Yu Kyeong Han, Ji Young Park, Yun Jung Park, Jin Ah Kim, Ji Yeon Lee, Yu Min Song, Hyung Ryong Moon
-
Patent number: 9216148Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: GrantFiled: February 8, 2012Date of Patent: December 22, 2015Assignee: Pusan National University Industry-University Cooperation FoundationInventors: Hae Young Chung, Hyung Ryong Moon, Min Hi Park, Young Mi Ha, Yun Jung Park, Ji Young Park, Jin Ah Kim, Ji Yeon Lee, Kyung Jin Lee
-
Patent number: 9168282Abstract: Disclosed is a method of treating pain. The method includes administering a lecithin as an active ingredient to a mammal to treat the pain, wherein the pain is caused by at least one of herpes zoster, post-herpetic neuralgia, and diabetic neuropathic pain. The method further includes administering at least one selected from the group consisting of vegetable gel, a vegetable resin, and a synthetic resin, wherein the vegetable gel, vegetable resin, and synthetic resin is selected from the group consisting of aloe gel; a seaweed extract selected from the group consisting of kelp extract, agar extract, and Fucoidan; and a mixture thereof.Type: GrantFiled: September 25, 2013Date of Patent: October 27, 2015Assignee: DONGKOOK PHARMACEUTICAL CO., LTD.Inventors: Jae-Hoon Jung, Hyung-Ryong Moon
-
Patent number: 9155690Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: GrantFiled: October 2, 2014Date of Patent: October 13, 2015Assignee: PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATIONInventors: Hae Young Chung, Min Hi Park, Young Mi Ha, Yu Kyeong Han, Ji Young Park, Yun Jung Park, Jin Ah Kim, Ji Yeon Lee, Yu Min Song, Hyung Ryong Moon
-
Publication number: 20150017111Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: ApplicationFiled: October 2, 2014Publication date: January 15, 2015Inventors: Hae Young Chung, Min Hi Park, Young Mi Ha, Yu Kyeong Han, Ji Young Park, Yun Jung Park, Jin Ah Kim, Ji Yeon Lee, Yu Min Song, Hyung Ryong Moon
-
Patent number: 8889881Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: GrantFiled: February 8, 2012Date of Patent: November 18, 2014Assignee: Pusan National University Industry —University Cooperation FoundationInventors: Hae Young Chung, Min Hi Park, Young Mi Ha, Yu Kyeong Han, Ji Young Park, Yun Jung Park, Jin Ah Kim, Ji Yeon Lee, Yu Min Song, Hyung Ryong Moon
-
Publication number: 20140037564Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: ApplicationFiled: February 8, 2012Publication date: February 6, 2014Applicant: Pusan National University IndusrtyuniversityInventors: Hae Young Chung, Min Hi Park, Young Mi Ha, Yu Kyeong Han, Ji Young Park, Yun Jung Park, Jin Ah Kim, Ji Yeon Lee, Yu Min Song, Hyung Ryong Moon
-
Publication number: 20140030366Abstract: Disclosed is a method of treating pain. The method includes administering a lecithin as an active ingredient to a mammal to treat the pain, wherein the pain is caused by at least one of herpes zoster, post-herpetic neuralgia, and diabetic neuropathic pain. The method further includes administering at least one selected from the group consisting of vegetable gel, a vegetable resin, and a synthetic resin, wherein the vegetable gel, vegetable resin, and synthetic resin is selected from the group consisting of aloe gel; a seaweed extract selected from the group consisting of kelp extract, agar extract, and Fucoidan; and a mixture thereof.Type: ApplicationFiled: September 25, 2013Publication date: January 30, 2014Applicant: MOON & J INC.Inventors: Jae-Hoon JUNG, Hyung-Ryong MOON
-
Publication number: 20140023603Abstract: Provided are a novel compound having skin-whitening, anti-oxidizing and PPAR activities and a medical use thereof, and the compound has skin-whitening activities for the suppression of tyrosinase, and accordingly, is useful for use in skin-whitening pharmaceutical composition or cosmetic products; has anti-oxidant activities, and accordingly, is useful for the prevention and treatment of skin-aging; and has PPAR activities, and in particular, PPAR? and PPAR? activities, and accordingly, is useful for use in pharmaceutical compositions or health foods which are effective for the prevention and treatment of obesity, metabolic disease, or cardiovascular disease.Type: ApplicationFiled: February 8, 2012Publication date: January 23, 2014Applicant: Pusan National University Industry-University Cooperation FoundationInventors: Hae Young Chung, Hyung Ryong Moon, Min Hi Park, Young Mi Ha, Yun Jung Park, Ji Young Park, Jin Ah Kim, Ji Yeon Lee, Kyung Jin Lee
-
Publication number: 20120053134Abstract: The present invention relates to a pharmaceutical composition for preventing or treating neuronal damage and neurological diseases, and more particularly, to a pharmaceutical composition for preventing or treating neuronal damage and neurological diseases containing, as active ingredients, any one or two or more compounds selected from a group consisting of the compound of chemical formula 1, the compound of chemical formula 2, and the acceptable salts thereof. The pharmaceutical composition repairs nerve tissue damaged by herpes zoster to reduce the acute pain caused by herpes zoster, prevents postherpetic neuralgia, and enables a fundamental treatment through the recovery of nerve tissue in the postherpetic neuralgia.Type: ApplicationFiled: May 6, 2010Publication date: March 1, 2012Inventors: Jae-Hoon Jung, Hyung-Ryong Moon
-
Patent number: 7199127Abstract: Disclosed are purine nucleoside compounds that are selective to A3 adenosine receptors and are useful for the treatment of cancer and inflammatory diseases. The compounds are shown by the following general formula (I), including isomers thereof: wherein X is sulfur or oxygen; R1 is hydrogen, alkyl, benzyl, halobenzyl, or phenylalkyl; R2 is hydrogen, halogen, alkoxy, alkenyl, alkynyl, alkylthio, or thio; R3 and R3? are hydrogen, hydroxyalkyl, alkoxycarbonyl, or alkylaminocarbonyl, whereas R3 and R3? do not have identical substituents simultaneously; and R4 is hydrogen or alkyl. Also disclosed are a pharmaceutical composition comprising a compound of formula (I), an isomer, or its pharmacologically acceptable salt as an active ingredient and a method for preventing or treating various diseases, state, or condition, including asthma, inflammation, cerebral ischemia, heart diseases, and cancer.Type: GrantFiled: October 24, 2003Date of Patent: April 3, 2007Assignees: United States of America, Represented by the Secretary, Department of Health and Human Services, Ewha Womans UniversityInventors: Lak Shin Jeong, Kenneth A. Jacobson, Hyung Ryong Moon, Hea Ok Kim